SHPHNasdaqPharmaceutical PreparationsFiscal year ends December 31
Shuttle Pharmaceuticals Holdings, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Sep 24, 2026
$4.72−0.36 (-7.09%)
Close on Oct 19, 2026
- Market cap
- $4.79M
- P/E (TTM)
- –
- Dividend yield
- –
Dividends
Shuttle Pharmaceuticals has not reported a dividend
No dividend per share appears in Shuttle Pharmaceuticals's annual filings since fiscal 2020.